SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

1 Nov 2022 07:00

RNS Number : 8199E
TP ICAP Group PLC
01 November 2022
 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

LEI: 2138006YAA7IRVKKGE63

 

1 November 2022

 

Trading update for the nine months ended 30 September 2022

 

 

Year-to-date performance (in constant currency, unless in brackets, which denotes reported currency)

 

Revenue

 

Total Group revenue of £1,588m in the first nine months of 2022 was up 10% (+15% in reported currency), compared with the same period in 2021. The Group benefitted from favourable market conditions in Global Broking, particularly in Rates, our largest, and most profitable, asset class. The ongoing strengthening of the US Dollar has been a meaningful tailwind: approximately 60% of the Group's revenue (and approximately 40% of costs) are US Dollar denominated. Excluding Liquidnet (completed on 23 March 2021), revenue increased by 7% (+12%).

 

At the divisional level, Global Broking revenue was up 9% (+14%). All asset classes generated high single digit to double digit growth. This performance underlines the strength of the franchise, which is well positioned as Central Banks continue to withdraw liquidity and increase interest rates.

 

In Energy & Commodities (E&C), revenue declined by 3% (+3%), in line with exchange volumes. Oil, our largest asset class in E&C, delivered low single digit growth. As previously reported, the European Gas & Power market is challenging: significant price rises and increased exchange margin requirements resulted in liquidity contracting and low levels of market activity.

 

Agency Execution revenue, including Liquidnet, was up 34% (+40%). Liquidnet revenue, on a proforma basis, declined by 9% (-7%). In Europe, there was a decline in larger block market trading activity. In the US, there was a shift in mix towards lower rate client segments. Liquidnet's market share in the US and Europe was broadly unchanged. Parameta Solutions revenue grew by 6% (+15%), with Data & Analytics (D&A) up 9% (+18%).

 

The Group, as a whole, continues to trade in line with the Board's expectations.

 

Third quarter performance (in constant currency, unless in brackets, which denotes reported currency)

 

During the third quarter of 2022, total Group revenue was £508m, up 5% (+14%) compared with the same period in 2021.

 

Global Broking revenue was up 12% (+20%). All asset classes generated high single digit to double digit growth, reflecting the continued strong performance. E&C revenue declined by 12% (-3%). In Agency Execution, including Liquidnet, revenue declined by 1% (+6%). Liquidnet revenue declined by 22% (-18%), reflecting the market conditions noted above. In addition, US Agency Alternative Trading System (ATS) volumes, a key contributor for Liquidnet, were subdued, compared with exchanges and OTC venues. Parameta Solutions revenue grew by 6% (+22%), while D&A revenue was up 7% (+24%).

 

2022 preliminary results

 

The Group will report its 2022 preliminary results on 14 March 2023. At the results, the Agency Execution division will be reported on a consolidated basis as Liquidnet.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries:

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 27 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFEIIILLVIF
Date   Source Headline
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.